Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy

Published:2020-12 Issue: Volume:261 Page:120347
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Shim Man Kyu,Moon Yujeong,Yang Suah,Kim Jinseong,Cho Hanhee,Lim Seungho,Yoon Hong Yeol,Seong Joon-Kyung,Kim Kwangmeyung

Funder

National Research Foundation

NRF

KU-KIST Graduate School of Converging Science and Technology

Korea University

KIST

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference47 articles.

1. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy;Choi;Canc. Cell,2014

2. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal;Tsuruo;Canc. Sci.,2003

3. Drug resistance in cancer: an overview;Housman;Cancers,2014

4. Temozolomide pharmacodynamics in patients with metastatic melanoma: Dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1;Plummer;Clin. Canc. Res.,2005

5. Multicenter phase II trial of temozolomide in mycosis fungoides/sézary syndrome: correlation with O6-methylguanine-DNA methyltransferase and mismatch repair proteins;Querfeld;Clin. Canc. Res.,2011

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in tumor stroma-based targeted delivery;International Journal of Pharmaceutics;2024-10

2. Engineered Carrier-Free Nanosystem-Induced In Situ Therapeutic Vaccines for Potent Cancer Immunotherapy;ACS Applied Materials & Interfaces;2024-08-27

3. Peptide-functionalized, -assembled and -loaded nanoparticles in cancer therapy;Drug Discovery Today;2024-07

4. Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy;Pharmaceutics;2024-06-12

5. Augmented antitumor immune responses of HER2-targeted pyroptotic induction by long-lasting recombinant immunopyroptotins;Heliyon;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3